Suppr超能文献

高敏肌钙蛋白在门诊环境中的使用实践模式。

Practice pattern of use of high sensitivity troponin in the outpatient settings.

机构信息

Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Center for Clinical Investigation, Brigham and Women's Hospital, Boston, Massachusetts, USA.

出版信息

Clin Cardiol. 2020 Dec;43(12):1573-1578. doi: 10.1002/clc.23482. Epub 2020 Oct 22.

Abstract

BACKGROUND

High-sensitivity troponin assays (hs-Tn) detect lower serum concentrations than prior-generation assays and help guide acute coronary syndrome (ACS) evaluation in emergency departments. Outpatient hs-Tn utilization is not well described.

HYPOTHESIS

Outpatient providers use hs-TnT to triage patients with suspected ACS.

METHODS

We compared the volume of outpatient prior-generation troponin tests in the pre-hsTn implementation period (January 2015-March 2018) with outpatient hs-TnT volume in the post-implementation period (April 2018-January 2020). Triage patterns were compared between patients with hs-TnT≥99th vs <99th percentile, using two-sample t tests. In patients triaged home, adverse events were compared between patients with hs-TnT≥99th vs <99th percentile, using log-rank tests.

RESULTS

Across a large tertiary healthcare system, a mean of 80 prior-generation tests/month were ordered during the pre-hsTn implementation period compared with 12 hs-TnT tests/month in the post-implementation period. Prior-generation orders rose by 1.72 tests/month during pre-implementation, vs a decline of 2.74 hs-TnT tests/month during post-implementation (P < .001). Among 129 hs-TnT orders, most were placed by cardiologists (54%) and primary care providers (32%). Patient symptoms at the time of troponin ordering included dyspnea (34%) and chest pain (33%), although 25% were asymptomatic. Among symptomatic patients (n = 74), those with hs-TnT > 99th percentile were more likely to be sent to the ED (RR, 3.36; 95% CI, 1.22-9.25; P = .002). Among patients sent home (n = 66), those with hs-TnT > 99th percentile had more adverse events by 6 months (3.3% vs 22.2% RR, 6.67; 95% CI, 1.04-42.9; P = .026).

CONCLUSIONS

In this healthcare system, outpatient troponin utilization significantly declined since hs-TnT implementation. Some providers use hs-TnT to triage patients with suspected ACS to the ED; others test asymptomatic patients and some send patients home despite high hs-TnT values.

摘要

背景

高敏肌钙蛋白检测(hs-Tn)检测到的血清浓度低于前一代检测方法,有助于指导急诊科急性冠状动脉综合征(ACS)的评估。门诊 hs-Tn 的使用情况尚未得到很好的描述。

假说

门诊医生使用 hs-TnT 对疑似 ACS 患者进行分诊。

方法

我们比较了 hs-TnT 实施前(2015 年 1 月至 2018 年 3 月)和实施后(2018 年 4 月至 2020 年 1 月)门诊前一代肌钙蛋白检测的检测量。使用两样本 t 检验比较 hs-TnT≥99 百分位与<99 百分位患者的分诊模式。使用对数秩检验比较 hs-TnT≥99 百分位与<99 百分位患者分诊回家后 6 个月内的不良事件。

结果

在一家大型三级医疗机构中,hs-TnT 实施前的平均每月检测量为 80 次,实施后的平均每月检测量为 12 次。在实施前,hs-TnT 检测量每月增加 1.72 次,而在实施后,hs-TnT 检测量每月减少 2.74 次(P<0.001)。在 129 例 hs-TnT 检测中,大部分由心脏病专家(54%)和初级保健医生(32%)开单。肌钙蛋白检测时患者的症状包括呼吸困难(34%)和胸痛(33%),但 25%的患者无症状。在有症状的患者中(n=74),hs-TnT>99 百分位的患者更有可能被送往急诊科(RR,3.36;95%CI,1.22-9.25;P=0.002)。在分诊回家的患者中(n=66),hs-TnT>99 百分位的患者在 6 个月内的不良事件发生率更高(3.3%比 22.2%;RR,6.67;95%CI,1.04-42.9;P=0.026)。

结论

在这个医疗体系中,自 hs-TnT 实施以来,门诊肌钙蛋白检测量显著下降。一些医生使用 hs-TnT 对疑似 ACS 的患者进行分诊至急诊科;另一些医生检测无症状患者,而一些医生尽管 hs-TnT 值较高,仍将患者分诊回家。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8199/7724219/2b72169e54f7/CLC-43-1573-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验